In this study, NK-92 cells labeled with Fe3O4-PEG-CD56/Avastin@Ce6 were used for in vitro and in vivo breast cancer adoptive cellular immunotherapy and PDT as well as MR/optical dual-modal imaging (Fig. 1). The gene discussed is NCAM1; the disease is breast cancer.